chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Lymph node on right side by collarbone became hard, painful, and swollen on March 22nd, ten days after my initial vaccination.; Lymph node on right side by collarbone became hard, painful, and swollen on March 22nd, ten days after my initial vaccination.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 05Apr2021 (Lot number: ER8737) as dose 2, single and administered in arm right, administration date 14Mar2021 10:45 (Lot number: EN6205) as dose 1, single for covid-19 immunisation. Relevant medical history included: "ADHD, combined type" (unspecified if ongoing), notes: ADHD, combined type; "Ehlers-Danlos syndrome" (unspecified if ongoing), notes: hypermobile Ehler's Danlos; "Asthma" (unspecified if ongoing), notes: Moderate to severe asthma. Concomitant medication(s) included: MONTELUKAST; ADDERALL; DULERA. The following information was reported: LYMPHADENOPATHY (non-serious), LYMPH NODE PAIN (non-serious) all with onset 22Mar2021, outcome "not recovered" and all described as "Lymph node on right side by collarbone became hard, painful, and swollen on March 22nd, ten days after my initial vaccination.". The event "lymph node on right side by collarbone became hard, painful, and swollen on march 22nd, ten days after my initial vaccination." and "lymph node on right side by collarbone became hard, painful, and swollen on march 22nd, ten days after my initial vaccination." was evaluated at the physician office visit. Therapeutic measures were not taken as a result of lymphadenopathy, lymph node pain.  Additional information: The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine.   No follow-up attempts are possible. No further information is expected.
10/05/2021- I was transferring from my bedside toilet back to bed, which I have done many times, and my legs gave out.  I was down for 12 hours. I did not know your body does not like that. The paramedics brought me to the ER, The Medical Center. I was there for an observation for 72 hours and then they admitted to the floor  because they could not rule out that I had an pulmonary embolism. Twice in rehab they found me unresponsive. I was transferred to rehab until the 10/25/2021. On 10/27 I was back in the hospital till  11/11/2021, when they found me unresponsive. On 11/12/2021- I was discharged back to rehab and that is where I am now.  I have been back to rehab 2, where I got my booster. I am back in rehab, because last week I tested positive for COVID-19, despite everything that I have done.  I received Pfizer as a booster  01/05/2022  Lot # FL3197,  the same day I got a positive result of COVID-19. The AEs are intense nausea. My question is : All of this that I have been through, does it confirm a pulmonary embolism as a result of the Johnson and Johnson vaccine?
Acute Ischemic Stroke / Cerebrovascular Accident right-sided weakness, pressure behind right eye and right sided headache. inability to grasp with right hand and  keep right leg up.  denies recent illness
soreness in the arm; fatigue; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in the arm), FATIGUE (fatigue) and PYREXIA (Low grade fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 22-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness in the arm), FATIGUE (fatigue) and PYREXIA (Low grade fever). At the time of the report, PAIN IN EXTREMITY (soreness in the arm), FATIGUE (fatigue) and PYREXIA (Low grade fever) outcome was unknown.            The patient was taking cholesterol medicines (unspecified).  No treatment information was provided.
This spontaneous report as received from a nurse refers to an 8 months 10 days old female patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) ROTATEQ lot # K016313, exp. date: 31-MAY-2016 and lot # K011663, exp. date: 20-MAY-2016 (dose and strength unspecified) oral. No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
Since having been vaccinated my menstrual cycles have been abnormal in flow and happening more frequently.
after HPV vaccine, went down for blood draw-passed out while drawing blood. Appeared pale-brought back to office-Rested approx 10 B/P 100/60 at 9:45 layed down-than sat up drinking juice @ 10:45 walking good color-sent home B/P 100/70
Non-bloody/non-bilious diarrhea changing to prolonged loose stools for 4 months with fecal urgency, and frequency for 4 months.
Information has been received from a registered pharmacist concerning a 69 year old female patient with herpes simplex and penicillin allergy who on 5-MAR-2008 was vaccinated with ZOSTAVAX SQ. On 26-JAN-2009, the patient had experienced increased severity in the presentation of herpes simplex lesions after receiving her ZOSTAVAX vaccination. The patient had spoken to a registered pharmacist for medical attention. Additional information has been requested.
The patient did not receive additional dose of M-M-R II after titer testing; The patient took a titer for measles to prove immunity instead, rather than use the MMR vaccine unnecessarily; This spontaneous report was received from a patient of unknown age and gender referring to himself/herself. The patient's concomitant medication, pertinent medical history and drug reactions/ allergies were not reported.      On an unknown date, the patient was vaccinated with the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) (dose, route of administration, anatomical location, lot number and expiration date were not reported) for prophylaxis. Additionally, the patient took a titer for measles to prove immunity instead, rather than get the second dose of the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) vaccine unnecessarily.
unconsolable crying from 10A-8P, red blotches on feet, awakened by mom q 2 hrs;thru noc per MD; slept 8P-8AM; afebrile, redness on rt thigh;
Client presented in office w/ grandmother 08/5/11 and stated since she woke up on 8/3, she had a reddened, warm swollen area around site that Varivax was given and its gotten increasingly bigger. Area = 2X3 in. Instructed client to seek care if worsens, recommended APAP/ibuprofen.
A 59yo female with PMH of Depression, Chronic PTSD, Cervical Radiculopathy, Anxiety, Migraine, Obesity and Tobacco use Per Nurses' documentation, she received Pfizer's Covid-19 vaccine First dose on April 5,2021 and second dose on April 26,2021 per policy and protocol without complication She was reported with a historical Pfizer Covid-19 vaccine induced reaction of Headache and confusion, by the attending physician on May 3, 2021
headaches; This is a spontaneous report received from a contactable consumer (reporting on herself). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number and Expiration Date was not reported) via an unspecified route of administration on an unspecified date, as 1st dose, single dose and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number and Expiration Date was not reported) via an unspecified route of administration on 31Mar2021, as 2nd dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that patient had her second shot, clarifies Pfizer Covid vaccine, last Wednesday, 31 Mar2021, states she has had headaches off and on since then and wants to know if this was natural. Patient had first shot, had headache but it went away, states this time it was on and off. The outcome of the event was unknow.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Stomachs ache every day since injection. Her ADHD has had the worst flare in years
A 4cm area, raised with induration. swelling traveled down arm to elbow to length of 15 cm. hot to the touch and tender. No drainage noted. Area of arm affected is front upper arm from site of injection to elbow. Assumed to be the pneumococcal vaccine injection. Pt further states that sx started with mild flu like symptoms: ha, fever, body aches, chills, and got progressively worse as day progressed.
Dose administered after a temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Dose administered after a temperature excursion) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034C21A, 044B21A and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Dose administered after a temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Dose administered after a temperature excursion) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Caller stated that they had a temperature excursion of about 20 doses of Moderna, it got down to 32°F, went up to 34°F, then up to 36°F, then up to 37°F over the course of an hour.The doses were put in a portable transport unit and left at 32°F, the transport unit wasn't prepared for enough time to maintain the temperature. Patient is immunocompromised. No concomitant medications were reported. No treatment medications were reported.
No vaccine was given.  The entry in system, for a covid vaccine with no lot number, 0n 9/28/202, at clinic, is completely in error.  There is a covid booster given five days later, which is why the discrepancy was noted.  Per the resident and his wife, on 9/28/22, no vaccine was given.  This is in error and makes it look like a reportable.  The resident did have: a covid booster on 10/03/2022 and a flu shot on 10/18/2022.  No side effects were reported from those.
difficulty walking; vertigo; dizziness; This is a spontaneous report received from contactable reporter(s) (Nurse) from a sales representative.  A patient (no qualifiers provided) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: GAIT DISTURBANCE (non-serious), outcome "unknown", described as "difficulty walking"; VERTIGO (non-serious), outcome "unknown"; DIZZINESS (non-serious), outcome "unknown".  Additional information: The patient had the same reaction as the reporter after receiving Prevnar 20.  The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300287168 same reporter/drug/event, different patients;
Information has been received from a 53 year old female registered nurse with no allergies or pertinent medical history who in 1997 or 1998 was subcutaneously vaccinated with two 0.5 mL doses of VARIVAX (Merck) (lot number not reported). There was no concomitant medication. Registered nurse reported that she had titers drawn in 2007 and they came back negative for immunity to the varicella virus (consumer reported that she had none further laboratories performed). The registered nurse did not seek medical attention. No treatment was given for this adverse event. At the time of the report the patient's outcome was unknown. Additional information has been requested.
This spontaneous report as received from a medical assistant refers to a 3 month old infant patient of unknown gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 05-OCT-2018, the patient was vaccinated with improperly stored dose of ROTATEQ 2 ml tube, orally (lot # N022015, expiry date: 10-MAR-2019) for prophylaxis. The vaccine was exposed to the temperature of 32.21 degree Fahrenheit (°F) (32F to 35 F) and time frame was 3.5 hours from 06-SEP-2018. Previous excursion was 50.37°F for 4.5 hours as recorded by a data logger. No adverse effect was reported. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1809USA002868: Original Case: 1809USA002868; US-009507513-1902USA009324: Original Case: 1902USA009323; US-009507513-1902USA009323: Original Case: 1902USA009323; US-009507513-1902USA009326: Original Case: 1902USA009323.
On the day of the shot, I was having severe joint pain in my shoulder, and elbow, was unable to move my arm at the shoulder at all without severe pain,  was not able to unbend my arm at all without severe pain.  After a week, I was having severe joint pain in my wrist and joint pain in my middle. Ring, and pinky fingers. After 2 weeks, I have limited mobility in my arm, still with severe pain in my shoulder, elbow, wrist and fingers.  After 3 week, I have more range of motion in my arm, but still limited with severe pain with certain movements.
Multiple maculopapular lesions on trunk and upper extremeties. Consistent with generalized vaccinia.
Patient became very lightheaded, dizzy and faint within 5 minutes of receiving vaccine. He was sweating heavily and very pale in the face. He was told to sit down and given some water and a cold cloth for his forehead. He remained seated for 20 minutes and began to feel better. He then left with his wife.
Information has been received from a physician concerning a 2month old female who on an unspecified date in 2007 was vaccinated with the first dose of Rotateq, 2 ml, oral. Concomitant medication was not reported. On an unspecified date in 2007, the patient experienced nausea and vomiting for one week after her first vaccination of Rotateq. The patient sought unspecified medical attention. Subsequently, the patient recovered from the nausea and vomiting after a week. No product quality complaint was involved. Additional information has been requested.
Patient is experiencing shoulder pain and mobility issues since receiving an influenza vaccination on 10/3/12.
As of Feb 3, 2022, patient has a sore arm. She has limited ROM of the left arm and cannot reach behind her back like she could before receiving the vaccine. The redness at the insertion site, noticed the day after the vaccine, now gone.
Cellulitis in leg; A spontaneous report was received from a consumer concerning 73-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced cellulitis in leg/cellulitis.    The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included Levothyroxine for thyroid medication, eye drops for glaucoma and baby aspirin for general health.  On 19 Feb 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: unknown) intramuscularly in the left upper arm for prophylaxis of COVID-19 infection.   On 19 Feb 2021, after first dose of vaccination, the patient experienced leg pain and a hot sensation in the leg. The patient reported that she went to an Urgent Care and was diagnosed with developing cellulitis in leg.  Treatment for the event included Bactrim, Doxycycline and Cipro.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the event, cellulitis in leg, was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported event of leg cellulitis, a causal relationship cannot be excluded.
Redness at injection site 3cm swelling. Hydrocortisone Cream. Painful trunk rash no treatment. Fine papular rash arms Hydrocortisone.
Sensitivity to light; Headache; Head pressure; This is a spontaneous report from a contactable healthcare professional, the patient. A 25-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Aug2021 at 12:15 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. On 29Aug2021, the patient experienced sensitivity to light, headache and head pressure. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sensitivity to light, headache and head pressure were not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Immediately after receiving the vaccine, the patient reports she began to experience redness/swelling/soreness in her arm in which she received the vaccine (though at the time it was mild enough that she attributed it to typical side effects from any vaccine). Within 3 days, she had developed a large, angry red patch covering her entire shoulder area. There were also symptoms of fever and flu-like symptoms, she reports. She did not visit her doctor regarding the symptoms, but has a photo of the inflammation in her arm. Even now, there is some residual redness/tenderness. She also notes a new small red/painful patch on her face (cheek) that she reports is painful and feels "similar" to how her arm did following the shingles vaccine. I advised her to follow up with her doctor at this time regarding both her lingering symptoms and new/worsening symptoms.
Dizziness, spinal pain, Pain all over the body, the injection arm, and chest. The chest pain is extreme.
Shortly after receiving Hepatitis A and Tdap vaccines had dyspnea and coughing along with redness of neck and tingling tongue - used ALBUTEROL inhaler and EPIPEN (administered by mother) and brought to ER where he was given PREDNISONE and observed.  8/19/09 ER records received for DOS 8/12/09 with dx:  Allergic reaction.  Pt presented with sx of anaphylaxis/coughing after receiving vax at PCP's office.  Given benadryl and epi at office as well as albuterol MDI.  PE (+) for erythroderma. Tx with steroids and d/c.
2 hours after receiving vaccine, muscle aches, headache, swelling at shot site, next day, arm swollen to armpit area and chest.
Rash-vesicular. Mupirocin ointment, 2 %, 1 app, applied topically. 3 times a day, 5 days, 22 grams.
This spontaneous report as received from a registered nurse and a Healthcare worker refers to a patient of unknown age and gender with no pertinent medical history/drug allergies or drug reactions reported. On 08-MAY-2015, the patient was vaccinated with an improperly stored dose of VARIVAX Lot# J013729 expiration date 30-OCT-2015 (route and dose were not reported). There was no concomitant therapy reported. The temperature excursion for the VARIVAX was unsupported with in house stability data. No adverse symptoms were reported. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report has been received from a pharmacist and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions, drug allergies/reactions, and concomitant therapies were not reported. It was reported by the pharmacist that on 01-APR-2017, the patient was vaccinated with an improperly stored dose of ZOSTAVAX (dose, route of administration, and frequency were not reported), for prophylaxis. A digital data logger was used.  No adverse effects were reported. This is one of multiple reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1704USA014153: US-009507513-1706USA001720: US-009507513-1706USA001721: US-009507513-1706USA001722: US-009507513-1706USA001723: US-009507513-1706USA001719: US-009507513-1706USA001724: US-009507513-1706USA001725: US-009507513-1706USA001726: US-009507513-1706USA001727: US-009507513-1706USA001714: US-009507513-1706USA001729:
Night of vaccination (several hours had elapsed), pt had episode of going limp, shallow breathing, circum oral cyanosis.  Slight fever had been noted.  Called paramedics-episode had resolved when they arrived.  Not taken to an ER.
Following the Moderna booster shot (I received the Johnson & Johnson vaccine on 4/11/21), I began to experience severe heartburn during and after strenuous exercise. The symptoms have persisted after I made dietary adjustments and took a 2-week course of over-the-counter omeprazole. Typically I might experience heartburn once a month or every other month, but never this often and never this severe.
shingles; Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age.  The patient's concurrent conditions, medical history and concomitant medications were not provided.   On or about 20-NOV-2015, the patient was vaccinated with a dose of zoster vaccine live (ZOSTAVAX) (lot #, dose, and frequency were not provided) for the long-term prevention of shingles and/or zoster-related conditions.        On an unknown date, subsequently to zoster vaccine live (ZOSTAVAX) vaccination, the patient was treated at clinic for shingles (herpes zoster). It was reported that as a direct and proximate result of  use of the zoster vaccine live (ZOSTAVAX) vaccine, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future.      The reporter considered herpes zoster to be related to the vaccination with Zoster Vaccine Live (ZOSTAVAX).